Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$64K Hold
11,570
﹤0.01% 246
2017
Q1
$67K Buy
+11,570
New +$63.5K ﹤0.01% 238
2016
Q4
Sell
-19,027
Closed -$115K 234
2016
Q3
$115K Sell
19,027
-2,244
-11% -$13.4K ﹤0.01% 198
2016
Q2
$126K Buy
21,271
+9,617
+83% +$51.6K 0.01% 205
2016
Q1
$60K Buy
11,654
+443
+4% +$2.04K ﹤0.01% 195
2015
Q4
$50K Sell
11,211
-13,469
-55% -$65.8K ﹤0.01% 178
2015
Q3
$121K Sell
24,680
-11,847
-32% -$64.3K 0.01% 289
2015
Q2
$223K Sell
36,527
-401
-1% -$2.48K 0.01% 310
2015
Q1
$213K Buy
36,928
+1,043
+3% +$6.47K 0.01% 324
2014
Q4
$223K Sell
35,885
-16,358
-31% -$103K 0.01% 302
2014
Q3
$342K Buy
52,243
+15,511
+42% +$109K 0.02% 208
2014
Q2
$259K Buy
36,732
+6,226
+20% +$45.8K 0.02% 261
2014
Q1
$226K Buy
30,506
+6,235
+26% +$43.6K 0.02% 277
2013
Q4
$178K Buy
+24,271
New +$177K 0.01% 289

Other funds holding ABEV

Ronald Blue & Co's ABEV Position: Q2 2017 in Review

Ronald Blue & Co held its Ambev (ABEV) position steady in Q2 2017 at 11,570 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #246.

Ronald Blue & Co first reported a position in ABEV in Q4 2013 and has held it in 14 quarters since. The position peaked at $342K in Q3 2014. 301 funds tracked by Wall St. Rank hold ABEV as of Q2 2017.

  • Ronald Blue & Co held 11,570 shares of Ambev worth $64K as of Q2 2017.
  • Ronald Blue & Co left its Ambev share count unchanged in Q2 2017.
  • Ambev made up ﹤0.01% of Ronald Blue & Co's portfolio in Q2 2017, its #246 holding.
  • Ronald Blue & Co first reported a position in Ambev in Q4 2013 and has held it in 14 quarters since.
  • Ronald Blue & Co's Ambev position peaked at $342K in Q3 2014.
  • 301 funds tracked by Wall St. Rank held Ambev as of Q2 2017.

Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.